Skip to content
World Brit Plus

Giving Stem Cells During Pregnancy to Infants with Neural Tube Defect Boosts Quality of Life, Trial Finds

A pioneering research effort has revealed that administering stem cells to fetuses affected by spina bifida as part of a surgical repair may represent a "significant breakthrough" in addressing congenital conditions.

Research Framework and Assurance

The US-based trial examined six unborn babies with a severe neural tube defect. Surgeons applied mother's placental stem cells on the exposed area of the infant's spine while the defect was being closed.

Significantly, the cell therapy proved to be secure. Doctors verified that the therapy did not induce neoplasms, interfere with wound healing, or prevent the reversal of related neurological issues.

Encouraging Results

Post-birth MRI scans showed a complete reversal of hindbrain herniation in each of the babies. This neurological improvement is strongly associated with enhanced physical outcomes.

"In the event it allows additional babies capable of walking who otherwise would not, then it would become their standard of care," said the lead researcher. "These findings are extremely promising and open the door to a variety of prospective novel therapies."

Long-Term Prospects and Optimism

Independent medical specialists have suggested that further confirmation of these observed advantages could herald a "new era" in prenatal intervention. The potential to improve neurological damage seen in utero is viewed as a transformative goal.

Especially significant would be better management of continence and digestive health, which are typical difficulties for people affected by this condition.

The Path Forward

Despite this being a first-in-human effort was small in scale, its established security and encouraging indicators create a solid basis for expanded clinical research. The addition of cellular treatment with proven prenatal surgical methods presents significant potential for transforming outcomes for infants diagnosed prenatally with myelomeningocele.

Written by

Dr. Richard Kelley PhD

A UK-based journalist with over a decade of experience covering British culture and current affairs, passionate about storytelling.

World Brit Plus

Type to search articles.